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Summary
Objective: This study assessed the utility and construct validity of a new patient global assessment of symptom change for hand osteoarthritis
(OA) by examining its associations with change over time in grip strength, pinch strength, and AUStralian CANadian Osteoarthritis Hand Index
(AUSCAN).
Methods: Participants (N¼ 531, 80% female, mean age¼ 68) were part of a study on the Genetics of Generalized Osteoarthritis (GOGO) and
completed two assessments (average 4 years apart). At the second assessment, participants described change in their right and left hand
pain, aching, and stiffness on a 15-point scale with descriptors ranging from ‘‘Great deal worse’’ to ‘‘Great deal better’’. Linear regression
models examined associations of global change scores with changes in hand strength and AUSCAN, controlling for age, gender, number
of hand joints with OA, and time between assessments.
Results: Both right and left hand global assessment of change scores were signiﬁcantly associated with change in AUSCAN, grip strength,
and right hand pinch strength (P< 0.05), and approached signiﬁcance for left hand pinch strength (P¼ 0.06). The strongest associations were
between global change scores and AUSCAN change (right hand: b¼ 0.29, P< 0.001; left hand: b¼ 0.27, P< 0.001). Associations of change
scores with grip and pinch strength were stronger among participants with greater radiographic OA severity at baseline.
Conclusion: Results support the validity of this new global assessment of symptom change. This measure is particularly useful for assessing
change over time when no baseline data are available. Additional research should examine this measure’s responsiveness in the context of
clinical trials.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Although the hand is commonly affected by osteoarthritis
(OA)1,2 there have been considerably fewer epidemiological
studies and clinical treatment trials regarding hand OA com-
pared to the number of studies in OA of the hip and knee3. In
addition, there is a lack of standardizedoutcomeassessments
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Received 15 March 2006; revision accepted 5 June 2006.128for studies involving hand OA4. The Osteoarthritis Research
Society International (OARSI) and the Outcome Measures in
Rheumatology Clinical Trials group (OMERACT) recommend
including patient global assessment as a key outcome in OA
trials5,6. Others have also speciﬁcally recommended patient
global assessment as a key outcome in the context of hand
OA7,8. While clinical tests are important objective measures,
it is also important to incorporate patients’ perceptions of their
OA symptoms, as well as changes in those symptoms.
Some OA studies, particularly clinical trials, have incorpo-
rated patient global assessments. However, these assess-
ments are most often administered pre- and post-treatment
and a change score calculated, similar to other scales3,9.
Fewer OA studies have utilized measures that examine
participants’ perceived response to treatment or change in
symptoms over time10,11. Furthermore, there is currently no
validated patient global assessment of change measure for
hand OA. This type of measure would have utility in the con-
text of clinical trials, epidemiological studies, and clinical set-
tings. The objective of this study was to examine a new1
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toms in the context of a longitudinal study of familial hand
OA. Speciﬁcally, we examined the construct validity of this
measure by examining relationships of participants’ per-
ceived change in symptoms with changes in grip strength,
pinch strength, and the AUStralian CANadian Osteoarthritis
Hand Index (AUSCAN)12,13.
Methods
SUBJECTS
All participants were enrolled in the Genetics of General-
ized Osteoarthritis (GOGO) study. The primary objective of
GOGO is to identify OA susceptibility genes through geno-
typing and linkage analysis of OA affected sibling pairs.
GOGO involves a consortium of seven clinical research
sites in the United States and United Kingdom14,15. Partici-
pants included in this analysis were from two GOGO sites:
Duke University and the University of North Carolina at
Chapel Hill.
All families recruited for the GOGO study had at least two
siblings with bilateral hand OA deﬁned as bony enlarge-
ment of at least one distal interphalangeal (DIP) joint, and
bony enlargement of two or more other interphalangeal
joints or carpometacarpal (CMC) joints. For these analyses,
we also required participants to have radiographic evidence
of Kellgren Lawrence (KL)16 grade 2 OA in at least one
DIP joint. We used this criterion because bony involvement
of a DIP joint is a component of the American College of
Rheumatology criteria for hand OA17, and a single Heber-
den’s node has been shown to be strongly inherited in a pre-
vious twin study18. All radiographs were read by a single
reader (JBR). Participants were excluded if they had self-re-
ported or x-ray evidence of arthritis from rheumatoid arthri-
tis, systemic lupus erythematosis, psoriasis, or gout of the
hands, hips or knees. Among 877 GOGO participants
who met criteria for these analyses at baseline, 531
(61%) completed follow-up assessments. The average
time between baseline and follow-up assessments was
4.1 years (SD¼ 1.1 years, range¼ 1.4e6.9 years).
AUSCAN
The AUSCAN is a 15-item scale measuring pain
(5 items), stiffness (1 item) and function (9 items) during
the preceding 48 h. All items are rated on a scale of 1
(none) to 5 (extreme), so that higher scores indicate worse
symptoms and function. The AUSCAN was developed
through an interactive process involving expert opinion
from health care providers (rheumatologists, physiothera-
pists, and orthopedic surgeons) and interviews with
patients. Items retained for this scale were those that had
a prevalence >60% in the sample population and a mean
importance rating >2.0 (on a scale of 1e5). Internal consis-
tency of the subscales was excellent (Cronbach’s
alpha¼ 0.90e0.98). Testeretest reliability was also accept-
able for each of the subscales (intraclass correlation coef-
ﬁcient¼ 0.70e0.86). Construct validity was conﬁrmed
against a variety of measures, including the Dreiser
Index19,20.
GRIP AND PINCH STRENGTH
Strength measures were performed on both hands. Grip
strength was measured with a Jamar Hydraulic HandDynamometer (reported in kilograms), and pinch strength
was measured with a Jamar Hydraulic Pinch Gauge
(Bolingbrook, IL) (also reported in kilograms). One site
(UNC) conducted three trials for grip and pinch strength
measurements, and an average of the three trials was cal-
culated. The other site (Duke) conducted one trial for each
measure. There were no differences in mean grip strength
measures between the sites, and results of study analyses
did not differ between sites.
GLOBAL ASSESSMENT OF CHANGE QUESTIONS
At the follow-up visit, all participants were asked, ‘‘Over-
all, has there been any change in your LEFT/RIGHT
HAND symptoms (pain, aching or stiffness) since your
last GOGO evaluation?’’ This question was asked sepa-
rately for right and left hands. Possible responses were:
Worse, About the same, Better, and No symptoms at the
ﬁrst GOGO visit and still no symptoms. Participants who
chose ‘‘Worse’’ were asked to describe how much worse,
using the following seven options: Almost the same e
hardly any worse at all; A little worse; Somewhat worse;
Moderately worse; A good deal worse; A great deal worse;
and A very great deal worse. Similarly, participants who
chose ‘‘Better’’ were asked to describe how much better,
using the same categories as for ‘‘Worse’’ but substituting
the adjective ‘‘Better’’. These questions were patterned af-
ter a global assessment of change scale for assessing
shortness of breath21. All participants who indicated their
symptoms had not changed (in the ﬁrst question) were
given a score of 0. Participants who had worse symptoms
were given a score between 1 and 7, based on the seven
categories for the degree of worsening listed above. Partic-
ipants whose symptoms were better were given a score
of 1 to 7, based on the categories listed above. There-
fore this change score encompassed 15 levels and ranged
from 7 to þ7 (including 0), with higher scores indicating
worse symptoms and function.
STATISTICAL ANALYSES
First, we used analysis of variance (ANOVA) to examine
differences in the mean change (between baseline and fol-
low-up) in AUSCAN, grip strength, and pinch strength ac-
cording to self-reported change category (‘‘Same’’,
‘‘Worse’’, or ‘‘Never had symptoms’’; the ‘‘Better’’ category
was omitted from this analysis because of the small num-
ber of participants, N¼ 13, who chose this response). Dis-
tributions of AUSCAN, grip strength, and pinch strength
change were inspected and did not appear to violate nor-
mality assumptions for use in ANOVA. We examined the
overall signiﬁcance level across categories for each of
these variables, then we examined differences between
each of the categories using Tukey’s test for simple com-
parisons. These analyses were also adjusted for age, gen-
der, total number of hand joints with KL 2 grade OA at
baseline, and time between assessments. Next, we used
linear regression models to examine relationships of self-
reported change scores (7 to þ7) with the change in
AUSCAN, grip strength, and pinch strength. These models
also controlled for age, gender, number of hand joints with
KL 2 grade OA, and time between assessments. We
conducted separate regression models examining the rela-
tionship of self-reported change scores to AUSCAN and
strength among men and women. These gender-speciﬁc
models controlled for age, number of hand joints with KL
2 grade OA, and time between assessments. We were
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the global assessment of change questions differed
according to overall baseline OA severity, as well as spe-
ciﬁc joint groups affected by OA. To examine overall radio-
graphic severity, we conducted separate regression
models according to the number of hand joints affected
by OA (KL 2 grade) at baseline, using tertile categories
(Tertile 1¼ 1e7 joints, Tertile 2¼ 8e15 joints, and Tertile
3¼ 16e27 joints). We also conducted separate models
for individuals with proximal interphalangeal (PIP) OA,
metacarpophalangeal (MCP) OA, and CMC OA (at least
one joint in the group with KL >2 grade OA). (All partici-
pants had DIP OA, so we did not conduct a separate anal-
ysis for this joint group.) All models stratiﬁed by
radiographic severity and joint group controlled for age,
gender, and time between assessments.
Results
The sample (N¼ 531) was 80% female and the mean
age was 67.7 years (SD¼ 8.2). Eighty-ﬁve percent of the
sample had PIP OA (77% right hand, 76% left hand),
27% had MCP OA (23% right hand, 16% left hand), and
53% had CMC OA (40% right hand, 47% left hand).
Ninety-three percent of the sample were right-handed.
When asked about the change in right hand symptoms,
about half of participants indicated symptoms were Worse,
2.5% responded ‘‘Better’’, 36.5% responded ‘‘Same’’, and
12.2% ‘‘Never had symptoms’’ (Table I). For the left hand,
a slightly lower proportion (43%) reported worsening symp-
toms and a slightly higher proportion (39.6%) reported
‘‘Same’’ symptoms. Women were more likely than men to
report worsening symptoms (51% vs 42% for right hand,
46% vs 34% for left hand). For the total sample, the mean
global assessment of change scores for the right and left
hands were 1.7 and 1.4, respectively. This corresponds to
a change between ‘‘Almost the same’’ and ‘‘A little worse’’.
Global assessment of change scores was slightly higher for
women than men, indicating women reported a greater de-
gree of worsening in symptoms.
Among the total sample, there was an increase of about
one point on the AUSCAN scale (which has a range of
15e75, with higher scores indicating worse symptoms;
Table I) between assessments. The change in AUSCAN
score was slightly higher for men than women. There were
only small changes in both grip strength and pinch strength
in the total sample (<1 kg), but these changes differed ac-
cording to gender (Table I). Males had an average decrease
in grip strength of 3.3 kg for both right and left hands, while
women, on average, had a slight increase in grip strength.
For analyses examining mean changes in AUSCAN, grip
strength, and pinch strength according to global assess-
ment of change categories, we omitted the ‘‘Better’’ cate-
gory because of the small number of participants who
chose this category. There was an overall statistically signif-
icant difference in the mean AUSCAN change according to
both right and left hand global assessment of change cate-
gories, controlling for age, gender, number of hand joints
with OA, and time between assessments (P< 0.001; Table
II). Participants reporting ‘‘Worse’’ symptoms had an in-
crease in AUSCAN score over time, and those reporting
‘‘Same’’ symptoms had minimal change in AUSCAN. For
both right and left hands, the AUSCAN change differed sig-
niﬁcantly between participants reporting ‘‘Worse’’ symptoms
and those reporting ‘‘Same’’ symptoms or ‘‘Never had
symptoms’’ (P< 0.05).There was an overall signiﬁcant difference in grip strength
change across right hand global assessment of change cat-
egories (P< 0.001) but not left hand categories (P¼ 0.152;
Table II). For both hands, those reporting ‘‘Worse’’ symp-
toms had a decline in grip strength, whereas those reporting
‘‘Same’’ symptoms had an increase in grip strength. For the
right hand, simple comparisons indicated that the change in
grip strength differed signiﬁcantly between those reporting
‘‘Worse’’ symptoms and those reporting ‘‘Same’’ symptoms
(P< 0.05). For change in pinch strength, there was a signif-
icant difference according to left hand global assessment of
change categories (P¼ 0.020), but the difference according
to right hand categories did not reach statistical signiﬁcance
(P¼ 0.084). However, for both hands, those with ‘‘Worse’’
symptoms had a small decrease in pinch strength over
time, and those with ‘‘Same’’ symptoms had a small in-
crease in pinch strength. For the left hand, simple compar-
isons showed that the change in pinch strength differed
signiﬁcantly between those reporting ‘‘Worse’’ and
‘‘Same’’ symptoms (P< 0.05).
Table I
Baseline and follow-up values for global assessment of change,
AUSCAN, and strength
Total
sample
(N¼ 531)
Males
(N¼ 105)
Females
(N¼ 426)
Right hand global assessment of change
Better (%) 2.5 1.0 2.8
Same (%) 36.5 41.0 35.5
Worse (%) 48.8 41.9 50.5
Never had symptoms (%) 12.2 16.1 11.3
Left hand global assessment of change
Better (%) 3.4 1.0 4.0
Same (%) 39.6 46.7 37.8
Worse (%) 43.3 34.3 45.5
Never had symptoms (%) 13.8 18.1 12.7
Mean (SD)
Number of hand joints
with OA
10.8 (5.7) 10.8 (5.7) 10.7 (6.0)
Right hand change score* 1.7 (2.3) 1.4 (1.9) 1.8 (2.4)
Left hand change score* 1.4 (2.3) 1.1 (1.7) 1.5 (2.4)
AUSCAN
Baseline 34.0 (12.3) 29.7 (10.2) 35.0 (12.6)
Follow-up 35.3 (13.0) 31.4 (12.0) 36.2 (13.0)
Change 1.3 (10.4) 1.7 (10.5) 1.2 (10.4)
Right grip strength (kg)
Baseline 50.0 (23.6) 79.3 (24.6) 43.2 (17.5)
Follow-up 50.0 (20.5) 75.1 (21.2) 43.3 (14.3)
Change 0.4 (15.4) 3.3 (18.7) 0.3 (14.4)
Left grip strength (kg)
Baseline 46.9 (24.0) 79.6 (25.0) 39.6 (17.2)
Follow-up 47.5 (20.6) 73.4 (20.5) 40.6 (14.0)
Change 0.4 (16.3) 3.3 (19.5) 1.3 (15.2)
Right pinch strength (kg)
Baseline 12.3 (5.9) 16.3 (5.8) 11.3 (5.5)
Follow-up 12.0 (5.0) 16.5 (531) 10.8 (4.2)
Change 0.4 (6.3) 0.2 (6.3) 0.4 (6.3)
Left pinch strength (kg)
Baseline 12.0 (6.1) 16.1 (5.6) 11.0 (5.8)
Follow-up 11.4 (4.7) 16.6 (4.7) 10.0 (3.6)
Change 0.7 (7.0) 1.2 (8.1) 1.2 (6.5)
For AUSCAN, positive change score¼worse. For strength,
positive change score¼ better.
*Range¼7 (better) to þ7 (worse).
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global assessment of change scores (7 to þ7) were signif-
icantly associated with change in total AUSCAN score, grip
strength, and right hand pinch strength, and approached
signiﬁcance for left hand pinch strength (P¼ 0.06; Table III).
The associations were strongest for the change in AUSCAN
score. There were signiﬁcant associations of right and left
hand global assessment of change scores with AUSCAN
change for both men and women (Table IV). Associations
of grip and pinch strength with change scores differed
somewhat between men and women (Table IV). For men,
there was a signiﬁcant association of right hand global as-
sessment of change score with right grip change but not
left grip change. For women, there was a signiﬁcant associ-
ation for left hand grip change but not right hand grip
change. The association between the global assessment
of change score and right hand grip strength change among
men (b¼0.39) was the largest of all relationships with
right and left hand global assessment of change scores.
Among women, there was a signiﬁcant association between
right hand pinch strength change and right hand global as-
sessment of score, but there were no signiﬁcant associa-
tions with pinch strength among men.
In models stratiﬁed according to the number of joints af-
fected by OA at baseline, there were signiﬁcant associations
of right and left hand change scores with AUSCAN change
for all three tertiles (P< 0.05, data not shown). However,
there were differences among the groups with respect to
grip and pinch change. For those in Tertile 1 (lowest number
of joints affected by OA), there were no signiﬁcant associa-
tions with right or left hand change scores with pinch or grip
strength (Table V). For those in Tertile 2, the only signiﬁcant
association was between right hand change score and right
Table II
Changes in AUSCAN and strength values according to global
assessment of change category
Mean (SD)
AUSCAN
change
Grip
strength
change
Pinch
strength
change
Right hand
Same 0.3 (9.1) 3.5 (15.1) 0.6 (6.8)
Worse 3.9 (10.6) 3.7 (15.7) 1.1 (6.2)
Never had
symptoms
3.9 (10.7) 2.0 (11.6) 0.6 (5.1)
Left hand
Same 0.4 (9.7) 2.3 (17.7) 1.3 (6.7)
Worse 4.3 (10.4) 1.3 (16.5) 0.3 (4.5)
Never had
symptoms
2.2 (10.6) 0.4 (10.6) 2.0 (3.7)
Note: For AUSCAN, positive change score¼worse. For
strength, positive change score¼ better.hand grip strength change (P< 0.05). For those in Tertile 3,
there were signiﬁcant associations of change scores with all
grip and pinch strength changes.
In models stratiﬁed according to joint group, there were
signiﬁcant associations of right and left hand change scores
with AUSCAN change for participants with PIP OA and
CMC OA (P< 0.05, data not shown). For MCP OA, there
was a signiﬁcant association between change score and
AUSCAN change for the right hand but not the left hand
(b¼0.39, P¼ 0.218). Similarly, there were signiﬁcant as-
sociations of right and left hand change scores with grip
strength change for participants with PIP and CMC OA,
as well as for the right hand (but not the left hand) among
those with MCP OA (Table VI). The strongest association
between change score and grip strength change was
among those with right MCP OA. For pinch strength, the
only signiﬁcant association with right and left hand change
scores was among the group with PIP OA (Table VI).
Discussion
This study examined relationships of a new global as-
sessment of symptom change for hand OA with changes
in grip strength, pinch strength, and AUSCAN score. The
study sample included individuals with familial hand OA
who completed baseline and follow-up assessments ap-
proximately 4 years apart, on average. We observed rela-
tively small changes over time in AUSCAN score and
hand strength, and as a whole, the sample indicated at fol-
low-up that their symptoms were between ‘‘Almost the
same’’ and ‘‘A little worse’’ compared to the baseline visit.
These results indicate that the global assessment of
change measure provided a good reﬂection of the
changes observed in the other measures across the entire
sample.
Women in the sample were more likely than men to report
that their symptoms were ‘‘Worse’’ since the baseline as-
sessment. Women also had a slightly higher change score
than men, indicating a greater magnitude of perceived
worsening in symptoms. However, men had a greater in-
crease in AUSCAN score and greater decline in grip
strength than women. These results indicate there may be
differences in the way men and women interpret and re-
spond to this global assessment of change item. Men
may be more reluctant than women to acknowledge an in-
crease in symptoms over time22. There also may be differ-
ences in the way men and women recall prior symptoms,
since this question asks individuals to compare current
symptoms to those experienced at an earlier time point.
These analyses showed that for the full sample, the
global assessment of change measure was signiﬁcantly as-
sociated with the change in AUSCAN score, as well as grip
and pinch strength. Although the sample as a whole dis-
played only small changes in AUSCAN and hand strength,Table III
Relationships of global assessment of change scores with AUSCAN and strength change: results of regression models
AUSCAN change Grip strength change Pinch strength change
b b P-value b b P-value b b P-value
Right change score 1.31 0.29 <0.001 1.08 0.16 0.003 0.37 0.13 0.022
Left change score 1.23 0.27 <0.001 0.96 0.13 0.015 0.34 0.11 0.060
Notes: b¼ non-standardized regression coefﬁcient, and b¼ standardized coefﬁcient. All models adjusted for age, gender, number of hand
joints with OA, and time between assessments.
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Relationships of global assessment of change scores with AUSCAN and strength change according to gender
AUSCAN change Grip strength change Pinch strength change
Males Females Males Females Males Females
b P-value b P-value b P-value b P-value b P-value b P-value
Right change score 0.35 <0.001 0.28 <0.001 0.39 <0.001 0.10 0.077 0.05 0.700 0.14 0.030
Left change score 0.25 0.013 0.28 <0.001 0.06 0.638 0.15 0.009 0.08 0.549 0.11 0.085
All models adjusted for age, number of hand joints with OA, and time between assessments.participants who indicated having ‘‘Worse’’ symptoms (com-
pared to baseline) had a markedly larger average increase
in AUSCAN and decrease in hand strength over time. The
global assessment of change score, when analyzed as
a 15-point scale, was also signiﬁcantly associated with
AUSCAN and hand strength for the total sample. Further-
more, changes in global assessment were associated with
clinically relevant differences in AUSCAN and hand
strength. For example, those who reported ‘‘Worse’’ symp-
toms had 7.2 kg lower mean right hand grip strength, 3.6 kg
lower mean left hand grip strength, and about a 4.5-point
greater AUSCAN score (on a 60-point scale). Even a one-
point difference on the 15-point global assessment of
change scale was associated with about 1 kg difference in
grip strength change and >1 point difference in AUSCAN.
While there is no consensus deﬁnition for a clinically rele-
vant difference in hand strength, the differences observed
in this study are large enough to affect daily tasks. For ex-
ample, one study showed that among older adults, the
mean force applied when opening certain various types of
containers ranged from 1.0 to 4.4 kg23. Therefore these re-
sults support both the validity and clinical utility of the global
assessment of change measure.
While the global assessment of change measure was sig-
niﬁcantly associated with the change in AUSCAN score for
both men and women, there were gender differences in the
relationship with hand strength. The association of global
change with pinch strength was somewhat stronger for
women than men. The largest gender difference, however,
was that the association of change score with right hand
grip strength change was much stronger for men than for
women. This is interesting, since the global assessment
of change measure asks about pain, aching, and stiffness,
but not strength or function. This stronger relationship
among men may indicate that when men are asked to recall
global changes in hand symptoms, hand strength (particu-
larly in right hand, which is the dominant hand for most in-
dividuals) is an important factor in this assessment.We also observed differences in the performance of the
global assessment of change questions according to base-
line severity of OA, deﬁned as the number of hand joints af-
fected by OA and grouped into tertiles. The two lower
tertiles did not show signiﬁcant associations between
change scores and hand strength change (except for a mar-
ginally signiﬁcant association for right hand grip strength in
the middle tertile). These results suggest that the global as-
sessment of change score may not be as sensitive a marker
of hand strength change among those with lower radio-
graphic OA severity. This may be due to the fact that indi-
viduals with less severe OA show smaller differences in
hand strength over time, and these small changes in
strength are not highly correlated with patients’ global as-
sessments of symptom change. In this sample, there was
not a statistically signiﬁcant difference in grip or pinch
strength change according to tertiles of affected joints at
baseline. However, there was a pattern for those in the
highest tertile to show larger decreases in pinch and grip
strength between assessments. There were signiﬁcant as-
sociations between global assessment of change scores
and AUSCAN change for all three tertiles of baseline OA
severity. Therefore these results support the construct val-
idity of the global assessment of change scores with re-
spect to measuring changes in patients’ self-reported
pain, stiffness, and function, regardless of their baseline
levels of OA severity.
We also found that global assessment of change scores
were associated with AUSCAN change among participants
with OA at each joint site (PIP, MCP, and CMC). This pro-
vides evidence that this measure is valid among individuals
with OA in different joint sites. However, we did observe dif-
ferent patterns of associations between global assessment
of change scores and hand strength across the joint groups.
Speciﬁcally, the strongest association between global
change score and grip strength was among those with right
hand MCP OA, and the strongest association between
global change score and pinch strength was among thoseTable V
Relationships of global assessment of change scores with strength change according to number of hand joints with OA
Grip strength change Pinch strength change
# OA joints e
Tertile 1
# OA joints e
Tertile 2
# OA joints e
Tertile 3
# OA joints e
Tertile 1
# OA joints e
Tertile 2
# OA joints e
Tertile 3
b P-value b P-value b P-value b P-value b P-value b P-value
Right change
score
0.08 0.418 0.17 0.050 0.21 0.017 0.06 0.578 0.08 0.079 0.24 0.013
Left change
score
0.15 0.133 0.04 0.656 0.18 0.041 0.04 0.670 0.01 0.926 0.23 0.012
All models adjusted for age, gender, and time between assessments. Tertile 1: 1e7 joints, Tertile 2: 8e15 joints, and Tertile 3: 16 or more
joints.
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Relationships of global assessment of change scores with strength change according to joint group with OA
Grip strength change Pinch strength change
PIP OA MCP OA CMC OA PIP OA MCP OA CMC OA
b P-value b P-value b P-value b P-value b P-value b P-value
Right change score 0.20 <0.001 0.34 <0.001 0.18 0.029 0.14 0.027 0.03 0.759 0.11 0.234
Left change score 0.17 0.005 0.09 0.483 0.20 0.008 0.14 0.030 0.11 0.427 0.09 0.303
All models adjusted for age, gender, and time between assessments.with PIP OA. These results indicate there may be differ-
ences in the speciﬁc types of hand strength changes (i.e.,
grip vs pinch) that drive patients’ global assessments ac-
cording to the joint site(s) affected by OA.
There are some limitations to measures that ask partici-
pants to assess response to treatment or changes in symp-
toms over time. First, these items require individuals to
recall their symptom severity during an earlier time point.
This may be difﬁcult for some individuals, particularly if
they are asked to assess change over a long duration. In
addition, there may be recall bias associated with these
measures. Some research suggests that assessments of
change and prior symptoms may be inﬂuenced by the se-
verity of present symptoms24e27. Additional research
should assess whether associations of this global assess-
ment of change measure with change in other measures
(such as AUSCAN or strength) differ according to the sever-
ity of current symptoms.
There are also several important strengths and potential
applications of this global assessment of change measure.
First, this item asks individuals to recall change in a very
speciﬁc aspect of health, and studies show that condition-
speciﬁc measures are more sensitive to change than global
measures of health status change28,29. Second, this item is
administered at a single time point but assesses change in
hand symptoms over a speciﬁed time interval. Therefore it
may be useful for assessing symptom change when base-
line data are not available. Third, this scale can be used
to assess the minimal perceptible improvement associated
with other scales related to hand symptoms30. Since this
measure assesses change in symptoms on a 15-point
scale, it can detect relatively small perceived changes.
Fourth, because this is a relatively brief measure, it can
be readily used in clinical settings to monitor patients’ re-
sponses to new treatments.
In summary, this study showed that a global assessment
of change measure was signiﬁcantly associated with actual
changes in both AUSCAN and hand strength. This provides
support for the validity and utility of this measure. Additional
research is needed to examine this measure in other patient
samples, and it would be of particular value to assess the
performance of this measure in the context of clinical trials.
Patients’ assessments of change and responses to treat-
ment are an important component of outcome measure-
ment in hand OA. This global assessment of change in
hand symptoms can be a valuable tool for assessing partic-
ipants perceived changes in the context of clinical trials and
epidemiological studies of hand OA.
Acknowledgements
This study would not have been possible without the aid of
the GOGO Consortium study personnel:
Duke University Medical Center: Ann Riley, Gabor Varju,
and Norine Hall.University of North Carolina: Patricia Cummins, Deborah
MacDonald, Amy Cohen, Janice Woodard, Kelly Neal,
Sarah Williams, and Tracey Jennings-Grant.
We also thank the Greensboro Hand Clinic, Carolina Ar-
thritis Associates, PA, Wilmington, NC; Durham Radiology,
Durham, NC; Drs Robert A. Harrell III, Franc A. Barada,
Linda R. Belhorn, and Anne K. Toohey, Durham, NC; Trian-
gle Orthopaedics, Durham, NC; Quik Med, Clayton, NC; Dr
James Holt, Sanford, NC; Caldwell Memorial Hospital/
Thompson Medical Specialists, Lenoir, NC; Dr Kate T.
Queen, Clyde, NC; Fearrington Community, Pittsboro, NC;
Drs Damon Anagnos, Donald Bynum, Beth L. Jonas, and
Alfredo Rivadeneira, University of North Carolina for their
assistance with recruitment.
Most especially we wish to thank the GlaxoSmithKline
sponsors: Drs Allen Roses and Lefkos Middleton and the
GOGO Scientiﬁc Coordinators (past and present) for their
invaluable assistance, Dr Scott Sundseth and Dr Uzma Atif.
The views expressed in this manuscript are those of the
authors and do not necessarily represent the views of the
Department of Veterans Affairs.
References
1. Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE,
Aliabadi P, Felson DT. Prevalence of symptomatic
hand osteoarthritis and its impact on functional status
among the elderly. Am J Epidemiol 2002;156(11):
1021e7.
2. Lawrence RC, Helmick CG, Arnette FC, Deyo RA,
Felson DT, Giannini EH, et al. Estimates of the preva-
lence of arthritis and selected musculoskeletal disor-
ders in the United States. Arthritis Rheum 1998;
41(5):778e99.
3. Mejjad O, Maheu E. Therapeutic trials in hand osteoar-
thritis: a critical review. Osteoarthritis Cartilage 2000;
8(Suppl A):S57e63.
4. Towheed TE. Systematic review of therapies for osteo-
arthritis of the hand. Osteoarthritis Cartilage 2005;13:
455e62.
5. Bellamy N, Kirwan J, Boers M, Brooks P, Strand V,
Tugwell P, et al. Recommendations for a core set of
outcome measures for future phase III clinical trials
in knee, hip, and hand osteoarthritis. Consensus de-
velopment at OMERACT III. J Rheumatol 1997;
24(4):799e802.
6. Pham T, van der Heijde D, Altman RD, Anderson JJ,
Bellamy N, Hochberg M, et al. OMERACTeOARSI ini-
tiative: Osteoarthritis Research Society International
set of responder criteria for osteoarthritis clinical trials.
Osteoarthritis Cartilage 2004;12:389e99.
7. Lequesne M, Maheu E. Methodology of clinical trials in
hand osteoarthritis: conventional and proposed tools.
Osteoarthritis Cartilage 2000;8(Suppl A):S64e9.
1287Osteoarthritis and Cartilage Vol. 14, No. 128. Chevalier X, Mejjad O, Babini S. Methodology for the
assessment of treatments in hand osteoarthritis. Oste-
oarthritis Cartilage 2000;8(Suppl A):S70e2.
9. Meenagh GK, Patton J, Kynes C, Wright GD. A rando-
mised controlled trial of intra-articular corticosteroid in-
jection of the carpometacarpal joint of the thumb in
osteoarthritis. Ann Rheum Dis 2004;63(10):1260e3.
10. Tubach F, Ravaud P, Baron G, Falissard B, Logeart I,
Bellamy N, et al. Evaluation of clinically relevant
changes in patient reported outcomes in knee and
hip osteoarthritis: the minimal clinically important im-
provement. Ann Rheum Dis 2005;64(1):29e33.
11. Hoeksma HL, van den Ende CH, Breedveld FC,
Ronday HK, Dekker J. A comparison of the OARSI
response criteria with patient’s global assessment in
patients with osteoarthritis of the hip treated with
a non-pharmacological intervention. Osteoarthritis
Cartilage 2005;14(1):77e81.
12. Bellamy N, Campbell J, Haraoui B, Buchbinder R,
Hobby K, Roth JH, et al. Dimensionality and clinical
importance of pain and disability in hand osteoarthritis:
development of the Australian/Canadian (AUSCAN)
Osteoarthritis Hand Index. Osteoarthritis Cartilage
2002;10(11):855e62.
13. Bellamy N, Campbell J, Haraoui B, Gerecz-Simon E,
Buchbinder R, Hobby K, et al. Clinimetric properties
of the AUSCAN Osteoarthritis Hand Index: an evalua-
tion of reliability, validity, and responsiveness. Osteo-
arthritis Cartilage 2002;10(11):863e9.
14. Kraus VB, Li Y, Martin E, Jordan JA, Renner JB,
Doherty M, et al. Articular hypermobility and hand os-
teoarthritis. Arthritis Rheum 2004;50(7):2178e83.
15. Kraus VB, Jordan JM, Doherty M, Wilson AG, Mosko-
witz R, Hochberg M, et al. The genetics of generalized
osteoarthritis (GOGO) study: study design and evalu-
ation of osteoarthritis phenotypes (submitted for
publication).
16. Kellgren J, Lawrence J. Radiological assessment of os-
teoarthrosis. Ann Rheum Dis 1957;16:494e502.
17. Altman R, Alarcon G, Appelrouth D, Bloch D,
Borenstein D, Brandt K, et al. The American College
of Rheumatology criteria for the classiﬁcation and re-
porting of osteoarthritis of the hand. Arthritis Rheum
1990;33(11):1601e10.
18. Spector TD, Cicuttini F, Baker J, Loughlin J, Hart D.
Genetic inﬂuences on osteoarthritis in women: a twin
study. BMJ 1996;312:940e3.19. Dreiser RL, Maheu E, Guillou GB. Sensitivity to change
of the functional index for hand osteoarthritis. Osteoar-
thritis Cartilage 2000;(Suppl A):S25e8.
20. Dreiser RL, Maheu E, Guillou GB, Caspard H,
Grouin JM. Validation of an algofunctional index for
osteoarthritis of the hand. Rev Rhum Engl Ed 1995;
6(Suppl 1):43Se53S.
21. Jaeschke R, Singer J, Guyatt GH. Measurement of
health status: ascertaining the minimal clinically im-
portant difference. Control Clin Trials 1989;10(4):
407e15.
22. Daltroy LH, Larson MG, Eaton HM, Pillips CB,
Liang MH. Discrepancies between self-reported and
observed physical function in the elderly: the inﬂuence
of response shift and other factors. Soc Sci Med 1999;
48(11):1549e61.
23. Rahman N, Thomas JJ, Rice MS. The relationship be-
tween hand strength and the forces used to access
containers by well elderly persons. Am J Occup Ther
2002;56:78e85.
24. Linton SJ, Melin L. The accuracy of remembering
chronic pain. Pain 1982;13:281e5.
25. Stone AA, Broderick JE, Kaell AT, Delespaul PAEG,
Porter L. Does the peak end phenomenon observed
in laboratory pain studies apply to real world pain in
rheumatoid arthritis? Pain 2000;1:203e18.
26. Stratford PW, Binkley JM, Riddle DL, Guyatt GH. Sen-
sitivity to change of the RolandeMorris back pain
questionnaire: part I. Phys Ther 1998;78(11).
27. Herrmann D. Reporting current, past, and changed
health status: what we now about distortion. Med
Care 1995;39:897e906.
28. Chatman AB, Hyams SP, Neel JM, Binkley JM,
Stratford PW, Schomberg A, et al. The patient-
speciﬁc functional scale: measurement properties in
patients with knee dysfunction. Phys Ther 1997;77:
820e9.
29. Kopec JA, Esdaile JM, Abrahamowicz M, Abenhaim L,
Wood-Dauphinee S, Lamping DL, et al. The Quebec
back pain disability scale: measurement properties.
Spine 1995;20:341e52.
30. Ehrich EW, Davies GM, Watson DJ, Bolognese JA,
Seidenberg BC, Bellamy N. Minimal perceptible clini-
cal improvement with the Western Ontario and
McMaster Universities osteoarthritis index question-
naire and global assessments in patients with osteoar-
thritis. J Rheumatol 2000;27:2461e635.
